Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
2
×
clinical trials
deals
2
×
ipo
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
sanofi
venture capital
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
cerovene
cobimetinib
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
What
ipo
medicines
2
×
acquisitions
announced
bio
cancer
ceo
collabs
covid
daniel
deal
despite
drug
family
gilead
gilead’s
hardest
help
hit
hottest
hunters
introduce
month
o’day
plans
proteins
ras
reels
research
revolution
roundup
sciences
targets
transformative
years
Language
unset
Current search:
cancer
×
medicines
×
deals
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer